LivaNova (LIVN) EPS (Basic) Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.01% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 106.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.82% |
| Dec 31, 2025 | -45.63% |
| Sep 30, 2025 | -19.67% |
| Jun 30, 2025 | 66.67% |
| Mar 31, 2025 | -670.51% |
| Dec 31, 2024 | 232.26% |
| Sep 30, 2024 | 535.71% |
| Jun 30, 2024 | 1,400.00% |
| Mar 31, 2024 | -657.14% |
| Dec 31, 2023 | 933.33% |
| Sep 30, 2023 | 93.03% |
| Jun 30, 2023 | -93.55% |
| Mar 31, 2023 | 133.33% |
| Dec 31, 2022 | 160.00% |
| Sep 30, 2022 | -139.29% |
| Jun 30, 2022 | 126.96% |
| Mar 31, 2022 | 109.52% |
| Dec 31, 2021 | 99.14% |
| Sep 30, 2021 | -180.00% |
| Jun 30, 2021 | 36.46% |
| Mar 31, 2021 | -178.75% |
| Dec 31, 2020 | -3,015.00% |
| Sep 30, 2020 | -145.45% |
| Jun 30, 2020 | -201.67% |
| Mar 31, 2020 | 358.06% |
| Dec 31, 2019 | 104.60% |
| Sep 30, 2019 | 540.00% |
| Jun 30, 2019 | -293.55% |
| Mar 31, 2019 | -214.81% |
| Dec 31, 2018 | -559.09% |
| Sep 30, 2018 | -125.86% |
| Jun 30, 2018 | -67.37% |
| Mar 31, 2018 | -3.57% |
| Dec 31, 2017 | -6.45% |
| Sep 30, 2017 | 2,033.33% |
| Jun 30, 2017 | 427.78% |
| Mar 31, 2017 | 133.73% |
| Dec 31, 2016 | -36.30% |
| Dec 31, 2015 | -384.30% |
| Oct 18, 2015 | -247.69% |
| Apr 24, 2015 | -83.67% |